US FDA approves Cytokinetics’ heart disease drug

Dec 19 (Reuters) – The ‍U.S. Food and ‌Drug ‌Administration has approved Cytokinetics’ drug ​to ‍treat ​a rare ​heart ‍condition, the company said ‍on Friday.

(Reporting by ‍Kamal ‍Choudhury ​and ​Mariam ⁠Sunny in ‌Bengaluru; Editing by Shinjini ⁠Ganguli)